Terns Pharmaceuticals, Inc.(TERN)
18.08-0.17-0.93%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Terns Pharmaceuticals, Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Terns Pharmaceuticals, Inc.于2016年12月9日根据开曼群岛法律注册成立。于2020年12月29日，该公司根据开曼群岛公司法（2020年修订）进行撤销注册及根据特拉华州普通公司法第388条进行归化（方式为向特拉华州州务卿提交归化证书），据此，其注册成立司法管辖权由开曼群岛变更为特拉华州，TernsPharmaceuticals Inc.是一家临床阶段的生物制药公司，开发一系列小分子候选产品，以应对严重疾病，包括肿瘤学和肥胖症。- 11-04Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 11-03Form 8-K - Current report重要事件披露Form 8-K - Current report
- 10-22Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-05Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 08-05Form 8-K - Current report重要事件披露Form 8-K - Current report
- 06-16Form 8-K - Current report重要事件披露Form 8-K - Current report
- 05-22Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 05-08Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 05-08Form 8-K - Current report重要事件披露Form 8-K - Current report
- 03-20Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 03-20Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 03-20Form 8-K - Current report重要事件披露Form 8-K - Current report
- 02-24Form 8-K - Current report重要事件披露Form 8-K - Current report
- 02-20Form 8-K - Current report重要事件披露Form 8-K - Current report
- 02-06Form 8-K - Current report重要事件披露Form 8-K - Current report
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
18.16
今开
18.00
量比
0.18
最低
17.39
昨收
18.25
换手率
2.48%